연구용
제품 번호S1025
| 세포주 | 분석 유형 | 농도 | 배양 시간 | 제형 | 활성 설명 | PMID |
|---|---|---|---|---|---|---|
| NCI-H1975 | Growth Inhibition Assay | IC50=21.461 μM | SANGER | |||
| HT | Growth Inhibition Assay | IC50=21.4331 μM | SANGER | |||
| HUTU-80 | Growth Inhibition Assay | IC50=21.4336 μM | SANGER | |||
| PA-1 | Growth Inhibition Assay | IC50=21.2787 μM | SANGER | |||
| HOP-62 | Growth Inhibition Assay | IC50=21.2784 μM | SANGER | |||
| GI-1 | Growth Inhibition Assay | IC50=21.17 μM | SANGER | |||
| MC116 | Growth Inhibition Assay | IC50=21.0723 μM | SANGER | |||
| A375 | Growth Inhibition Assay | IC50=21.0567 μM | SANGER | |||
| IST-SL1 | Growth Inhibition Assay | IC50=20.7879 μM | SANGER | |||
| TE-5 | Growth Inhibition Assay | IC50=20.7482 μM | SANGER | |||
| SiHa | Growth Inhibition Assay | IC50=20.3712 μM | SANGER | |||
| LB2518-MEL | Growth Inhibition Assay | IC50=20.3739 μM | SANGER | |||
| BB49-HNC | Growth Inhibition Assay | IC50=19.92 μM | SANGER | |||
| HGC-27 | Growth Inhibition Assay | IC50=20.1394 μM | SANGER | |||
| Becker | Growth Inhibition Assay | IC50=19.8547 μM | SANGER | |||
| TYK-nu | Growth Inhibition Assay | IC50=19.8378 μM | SANGER | |||
| NCI-H650 | Growth Inhibition Assay | IC50=19.7508 μM | SANGER | |||
| WM-115 | Growth Inhibition Assay | IC50=19.6774 μM | SANGER | |||
| HuH-7 | Growth Inhibition Assay | IC50=19.7421 μM | SANGER | |||
| NCI-N87 | Growth Inhibition Assay | IC50=19.5992 μM | SANGER | |||
| NCI-H1048 | Growth Inhibition Assay | IC50=19.2326 μM | SANGER | |||
| NCI-H446 | Growth Inhibition Assay | IC50=19.3589 μM | SANGER | |||
| NCI-H1437 | Growth Inhibition Assay | IC50=19.0467 μM | SANGER | |||
| D-263MG | Growth Inhibition Assay | IC50=19.0172 μM | SANGER | |||
| MFH-ino | Growth Inhibition Assay | IC50=18.9669 μM | SANGER | |||
| U-266 | Growth Inhibition Assay | IC50=18.8649 μM | SANGER | |||
| OVCAR-8 | Growth Inhibition Assay | IC50=18.9276 μM | SANGER | |||
| KNS-42 | Growth Inhibition Assay | IC50=18.8015 μM | SANGER | |||
| U251 | Growth Inhibition Assay | IC50=18.7347 μM | SANGER | |||
| MFE-280 | Growth Inhibition Assay | IC50=18.7293 μM | SANGER | |||
| NCI-H1563 | Growth Inhibition Assay | IC50=18.7124 μM | SANGER | |||
| MDA-MB-361 | Growth Inhibition Assay | IC50=18.5588 μM | SANGER | |||
| HLE | Growth Inhibition Assay | IC50=18.3148 μM | SANGER | |||
| SW982 | Growth Inhibition Assay | IC50=18.4075 μM | SANGER | |||
| KM-H2 | Growth Inhibition Assay | IC50=17.9411 μM | SANGER | |||
| D-502MG | Growth Inhibition Assay | IC50=17.9808 μM | SANGER | |||
| ES8 | Growth Inhibition Assay | IC50=17.8593 μM | SANGER | |||
| SF268 | Growth Inhibition Assay | IC50=17.6969 μM | SANGER | |||
| Calu-6 | Growth Inhibition Assay | IC50=17.6782 μM | SANGER | |||
| SW1783 | Growth Inhibition Assay | IC50=17.6415 μM | SANGER | |||
| NCI-H747 | Growth Inhibition Assay | IC50=17.5297 μM | SANGER | |||
| NCI-H1573 | Growth Inhibition Assay | IC50=17.2826 μM | SANGER | |||
| NCI-H1581 | Growth Inhibition Assay | IC50=17.4411 μM | SANGER | |||
| RKO | Growth Inhibition Assay | IC50=17.0748 μM | SANGER | |||
| MZ2-MEL | Growth Inhibition Assay | IC50=17.133 μM | SANGER | |||
| GI-ME-N | Growth Inhibition Assay | IC50=16.9032 μM | SANGER | |||
| LB373-MEL-D | Growth Inhibition Assay | IC50=16.7232 μM | SANGER | |||
| MEL-HO | Growth Inhibition Assay | IC50=16.8854 μM | SANGER | |||
| BEN | Growth Inhibition Assay | IC50=16.5155 μM | SANGER | |||
| M059J | Growth Inhibition Assay | IC50=16.284 μM | SANGER | |||
| D-283MED | Growth Inhibition Assay | IC50=16.4209 μM | SANGER | |||
| GP5d | Growth Inhibition Assay | IC50=16.2187 μM | SANGER | |||
| BHT-101 | Growth Inhibition Assay | IC50=16.2439 μM | SANGER | |||
| HT55 | Growth Inhibition Assay | IC50=15.9478 μM | SANGER | |||
| no-11 | Growth Inhibition Assay | IC50=15.9663 μM | SANGER | |||
| MPP-89 | Growth Inhibition Assay | IC50=15.9417 μM | SANGER | |||
| HuCCT1 | Growth Inhibition Assay | IC50=15.874 μM | SANGER | |||
| NCI-H23 | Growth Inhibition Assay | IC50=15.8438 μM | SANGER | |||
| UMC-11 | Growth Inhibition Assay | IC50=15.7523 μM | SANGER | |||
| MCF7 | Growth Inhibition Assay | IC50=15.8145 μM | SANGER | |||
| COLO-320-HSR | Growth Inhibition Assay | IC50=15.5307 μM | SANGER | |||
| CW-2 | Growth Inhibition Assay | IC50=15.1421 μM | SANGER | |||
| MOLT-4 | Growth Inhibition Assay | IC50=15.0497 μM | SANGER | |||
| NCI-H1755 | Growth Inhibition Assay | IC50=14.9953 μM | SANGER | |||
| MIA-PaCa-2 | Growth Inhibition Assay | IC50=14.969 μM | SANGER | |||
| TGBC1TKB | Growth Inhibition Assay | IC50=14.6615 μM | SANGER | |||
| NCI-H630 | Growth Inhibition Assay | IC50=14.9467 μM | SANGER | |||
| LAN-6 | Growth Inhibition Assay | IC50=14.253 μM | SANGER | |||
| A549 | Growth Inhibition Assay | IC50=14.4712 μM | SANGER | |||
| RD | Growth Inhibition Assay | IC50=14.4813 μM | SANGER | |||
| KALS-1 | Growth Inhibition Assay | IC50=13.8525 μM | SANGER | |||
| LOXIMVI | Growth Inhibition Assay | IC50=13.6151 μM | SANGER | |||
| SK-PN-DW | Growth Inhibition Assay | IC50=13.8427 μM | SANGER | |||
| SN12C | Growth Inhibition Assay | IC50=13.3808 μM | SANGER | |||
| NCI-H1993 | Growth Inhibition Assay | IC50=13.4285 μM | SANGER | |||
| G-361 | Growth Inhibition Assay | IC50=12.9129 μM | SANGER | |||
| RH-18 | Growth Inhibition Assay | IC50=13.2962 μM | SANGER | |||
| GT3TKB | Growth Inhibition Assay | IC50=12.6327 μM | SANGER | |||
| DMS-273 | Growth Inhibition Assay | IC50=12.8633 μM | SANGER | |||
| C3A | Growth Inhibition Assay | IC50=12.5785 μM | SANGER | |||
| Daoy | Growth Inhibition Assay | IC50=12.4542 μM | SANGER | |||
| ABC-1 | Growth Inhibition Assay | IC50=12.341 μM | SANGER | |||
| KS-1 | Growth Inhibition Assay | IC50=12.2832 μM | SANGER | |||
| JAR | Growth Inhibition Assay | IC50=12.3369 μM | SANGER | |||
| CAMA-1 | Growth Inhibition Assay | IC50=12.1633 μM | SANGER | |||
| U-118-MG | Growth Inhibition Assay | IC50=12.2441 μM | SANGER | |||
| OE19 | Growth Inhibition Assay | IC50=11.9367 μM | SANGER | |||
| Mo-T | Growth Inhibition Assay | IC50=11.9541 μM | SANGER | |||
| SCC-9 | Growth Inhibition Assay | IC50=11.8151 μM | SANGER | |||
| HOS | Growth Inhibition Assay | IC50=11.8683 μM | SANGER | |||
| UM-UC-3 | Growth Inhibition Assay | IC50=11.7421 μM | SANGER | |||
| MMAC-SF | Growth Inhibition Assay | IC50=11.7252 μM | SANGER | |||
| MLMA | Growth Inhibition Assay | IC50=11.6997 μM | SANGER | |||
| RPMI-7951 | Growth Inhibition Assay | IC50=11.6348 μM | SANGER | |||
| NCI-H1299 | Growth Inhibition Assay | IC50=11.6647 μM | SANGER | |||
| LS-411N | Growth Inhibition Assay | IC50=11.6101 μM | SANGER | |||
| HCC1954 | Growth Inhibition Assay | IC50=11.436 μM | SANGER | |||
| GOTO | Growth Inhibition Assay | IC50=11.5206 μM | SANGER | |||
| FTC-133 | Growth Inhibition Assay | IC50=11.3081 μM | SANGER | |||
| LB831-BLC | Growth Inhibition Assay | IC50=11.2556 μM | SANGER | |||
| HCC38 | Growth Inhibition Assay | IC50=10.9716 μM | SANGER | |||
| SF-295 | Growth Inhibition Assay | IC50=10.9902 μM | SANGER | |||
| K-562 | Growth Inhibition Assay | IC50=10.8395 μM | SANGER | |||
| SW900 | Growth Inhibition Assay | IC50=10.8228 μM | SANGER | |||
| D-336MG | Growth Inhibition Assay | IC50=10.7005 μM | SANGER | |||
| LXF-289 | Growth Inhibition Assay | IC50=10.7967 μM | SANGER | |||
| SW962 | Growth Inhibition Assay | IC50=10.6204 μM | SANGER | |||
| VMRC-RCZ | Growth Inhibition Assay | IC50=10.6749 μM | SANGER | |||
| HEC-1 | Growth Inhibition Assay | IC50=10.4081 μM | SANGER | |||
| A2058 | Growth Inhibition Assay | IC50=10.5491 μM | SANGER | |||
| K5 | Growth Inhibition Assay | IC50=10.3395 μM | SANGER | |||
| U031 | Growth Inhibition Assay | IC50=10.2686 μM | SANGER | |||
| YH-13 | Growth Inhibition Assay | IC50=10.3057 μM | SANGER | |||
| SK-UT-1 | Growth Inhibition Assay | IC50=10.2574 μM | SANGER | |||
| NCI-H810 | Growth Inhibition Assay | IC50=10.1597 μM | SANGER | |||
| DJM-1 | Growth Inhibition Assay | IC50=10.1732 μM | SANGER | |||
| CAL-51 | Growth Inhibition Assay | IC50=10.0877 μM | SANGER | |||
| HCE-4 | Growth Inhibition Assay | IC50=10.1122 μM | SANGER | |||
| NCI-H2342 | Growth Inhibition Assay | IC50=10.0155 μM | SANGER | |||
| A204 | Growth Inhibition Assay | IC50=10.0466 μM | SANGER | |||
| NCI-H1355 | Growth Inhibition Assay | IC50=9.94088 μM | SANGER | |||
| SW837 | Growth Inhibition Assay | IC50=9.8482 μM | SANGER | |||
| OCI-AML2 | Growth Inhibition Assay | IC50=9.8696 μM | SANGER | |||
| EFO-21 | Growth Inhibition Assay | IC50=9.58735 μM | SANGER | |||
| C32 | Growth Inhibition Assay | IC50=9.6334 μM | SANGER | |||
| KP-4 | Growth Inhibition Assay | IC50=9.48838 μM | SANGER | |||
| A101D | Growth Inhibition Assay | IC50=9.51719 μM | SANGER | |||
| IA-LM | Growth Inhibition Assay | IC50=9.41966 μM | SANGER | |||
| HPAF-II | Growth Inhibition Assay | IC50=9.22518 μM | SANGER | |||
| Capan-2 | Growth Inhibition Assay | IC50=9.40109 μM | SANGER | |||
| BFTC-909 | Growth Inhibition Assay | IC50=9.18297 μM | SANGER | |||
| RPMI-8226 | Growth Inhibition Assay | IC50=9.11304 μM | SANGER | |||
| ChaGo-K-1 | Growth Inhibition Assay | IC50=9.10579 μM | SANGER | |||
| NCI-H2228 | Growth Inhibition Assay | IC50=9.11081 μM | SANGER | |||
| NCI-H226 | Growth Inhibition Assay | IC50=9.09 μM | SANGER | |||
| D-566MG | Growth Inhibition Assay | IC50=9.0181 μM | SANGER | |||
| LS-1034 | Growth Inhibition Assay | IC50=8.94652 μM | SANGER | |||
| NCI-H1792 | Growth Inhibition Assay | IC50=8.88903 μM | SANGER | |||
| COLO-792 | Growth Inhibition Assay | IC50=8.74946 μM | SANGER | |||
| A673 | Growth Inhibition Assay | IC50=8.67611 μM | SANGER | |||
| D-392MG | Growth Inhibition Assay | IC50=8.66214 μM | SANGER | |||
| EGI-1 | Growth Inhibition Assay | IC50=8.60088 μM | SANGER | |||
| TGBC11TKB | Growth Inhibition Assay | IC50=8.46164 μM | SANGER | |||
| 5637 | Growth Inhibition Assay | IC50=8.31055 μM | SANGER | |||
| KYSE-70 | Growth Inhibition Assay | IC50=8.19761 μM | SANGER | |||
| VM-CUB-1 | Growth Inhibition Assay | IC50=8.17029 μM | SANGER | |||
| AM-38 | Growth Inhibition Assay | IC50=8.1628 μM | SANGER | |||
| NCI-H661 | Growth Inhibition Assay | IC50=8.05867 μM | SANGER | |||
| SHP-77 | Growth Inhibition Assay | IC50=7.86653 μM | SANGER | |||
| DK-MG | Growth Inhibition Assay | IC50=7.83201 μM | SANGER | |||
| NB13 | Growth Inhibition Assay | IC50=7.82667 μM | SANGER | |||
| COLO-829 | Growth Inhibition Assay | IC50=7.66463 μM | SANGER | |||
| OS-RC-2 | Growth Inhibition Assay | IC50=7.49894 μM | SANGER | |||
| HCC1419 | Growth Inhibition Assay | IC50=7.46833 μM | SANGER | |||
| SKG-IIIa | Growth Inhibition Assay | IC50=7.45381 μM | SANGER | |||
| COLO-668 | Growth Inhibition Assay | IC50=7.43967 μM | SANGER | |||
| CAL-62 | Growth Inhibition Assay | IC50=7.39866 μM | SANGER | |||
| HEL | Growth Inhibition Assay | IC50=7.37521 μM | SANGER | |||
| NCI-H2030 | Growth Inhibition Assay | IC50=7.33698 μM | SANGER | |||
| DMS-114 | Growth Inhibition Assay | IC50=7.29631 μM | SANGER | |||
| NOS-1 | Growth Inhibition Assay | IC50=7.25828 μM | SANGER | |||
| KP-N-YS | Growth Inhibition Assay | IC50=7.1814 μM | SANGER | |||
| OVCAR-4 | Growth Inhibition Assay | IC50=7.1535 μM | SANGER | |||
| NCI-H2405 | Growth Inhibition Assay | IC50=7.08393 μM | SANGER | |||
| TE-11 | Growth Inhibition Assay | IC50=7.04967 μM | SANGER | |||
| KLE | Growth Inhibition Assay | IC50=6.96516 μM | SANGER | |||
| A388 | Growth Inhibition Assay | IC50=6.8952 μM | SANGER | |||
| NB12 | Growth Inhibition Assay | IC50=6.78404 μM | SANGER | |||
| PFSK-1 | Growth Inhibition Assay | IC50=6.73478 μM | SANGER | |||
| SK-HEP-1 | Growth Inhibition Assay | IC50=6.71753 μM | SANGER | |||
| Calu-3 | Growth Inhibition Assay | IC50=6.65568 μM | SANGER | |||
| SH-4 | Growth Inhibition Assay | IC50=6.58844 μM | SANGER | |||
| GCT | Growth Inhibition Assay | IC50=6.53387 μM | SANGER | |||
| MSTO-221H | Growth Inhibition Assay | IC50=6.5117 μM | SANGER | |||
| GAMG | Growth Inhibition Assay | IC50=6.5062 μM | SANGER | |||
| CAL-120 | Growth Inhibition Assay | IC50=6.45162 μM | SANGER | |||
| VA-ES-BJ | Growth Inhibition Assay | IC50=6.30462 μM | SANGER | |||
| SK-MEL-28 | Growth Inhibition Assay | IC50=6.20967 μM | SANGER | |||
| 8-MG-BA | Growth Inhibition Assay | IC50=6.19379 μM | SANGER | |||
| L-428 | Growth Inhibition Assay | IC50=6.18037 μM | SANGER | |||
| Mewo | Growth Inhibition Assay | IC50=6.11487 μM | SANGER | |||
| RCM-1 | Growth Inhibition Assay | IC50=6.07719 μM | SANGER | |||
| KE-37 | Growth Inhibition Assay | IC50=6.07258 μM | SANGER | |||
| TE-10 | Growth Inhibition Assay | IC50=6.04833 μM | SANGER | |||
| HDLM-2 | Growth Inhibition Assay | IC50=6.01489 μM | SANGER | |||
| CAKI-1 | Growth Inhibition Assay | IC50=6.00985 μM | SANGER | |||
| RT-112 | Growth Inhibition Assay | IC50=5.90245 μM | SANGER | |||
| HCC2998 | Growth Inhibition Assay | IC50=5.71877 μM | SANGER | |||
| HCC1187 | Growth Inhibition Assay | IC50=5.71032 μM | SANGER | |||
| HD-MY-Z | Growth Inhibition Assay | IC50=5.68581 μM | SANGER | |||
| RMG-I | Growth Inhibition Assay | IC50=5.65942 μM | SANGER | |||
| BFTC-905 | Growth Inhibition Assay | IC50=5.65878 μM | SANGER | |||
| SW1990 | Growth Inhibition Assay | IC50=5.62285 μM | SANGER | |||
| SW13 | Growth Inhibition Assay | IC50=5.53265 μM | SANGER | |||
| AGS | Growth Inhibition Assay | IC50=5.49618 μM | SANGER | |||
| ATN-1 | Growth Inhibition Assay | IC50=5.41184 μM | SANGER | |||
| CGTH-W-1 | Growth Inhibition Assay | IC50=5.38584 μM | SANGER | |||
| NOMO-1 | Growth Inhibition Assay | IC50=5.23176 μM | SANGER | |||
| ALL-PO | Growth Inhibition Assay | IC50=5.22587 μM | SANGER | |||
| KP-N-YN | Growth Inhibition Assay | IC50=5.12591 μM | SANGER | |||
| NCI-H1838 | Growth Inhibition Assay | IC50=5.02076 μM | SANGER | |||
| TE-9 | Growth Inhibition Assay | IC50=5.01525 μM | SANGER | |||
| KOSC-2 | Growth Inhibition Assay | IC50=4.99959 μM | SANGER | |||
| ES1 | Growth Inhibition Assay | IC50=4.96035 μM | SANGER | |||
| KNS-62 | Growth Inhibition Assay | IC50=4.90807 μM | SANGER | |||
| KYSE-520 | Growth Inhibition Assay | IC50=4.88018 μM | SANGER | |||
| P30-OHK | Growth Inhibition Assay | IC50=4.81929 μM | SANGER | |||
| NB10 | Growth Inhibition Assay | IC50=4.59781 μM | SANGER | |||
| A172 | Growth Inhibition Assay | IC50=4.55521 μM | SANGER | |||
| SK-OV-3 | Growth Inhibition Assay | IC50=4.46042 μM | SANGER | |||
| GR-ST | Growth Inhibition Assay | IC50=4.4318 μM | SANGER | |||
| HCC1937 | Growth Inhibition Assay | IC50=4.37993 μM | SANGER | |||
| LU-139 | Growth Inhibition Assay | IC50=4.37247 μM | SANGER | |||
| SNU-C2B | Growth Inhibition Assay | IC50=4.34686 μM | SANGER | |||
| KARPAS-299 | Growth Inhibition Assay | IC50=4.31013 μM | SANGER | |||
| EW-11 | Growth Inhibition Assay | IC50=4.13261 μM | SANGER | |||
| HL-60 | Growth Inhibition Assay | IC50=4.12241 μM | SANGER | |||
| TCCSUP | Growth Inhibition Assay | IC50=4.1105 μM | SANGER | |||
| RCC10RGB | Growth Inhibition Assay | IC50=4.01246 μM | SANGER | |||
| NCI-H441 | Growth Inhibition Assay | IC50=3.97014 μM | SANGER | |||
| EW-16 | Growth Inhibition Assay | IC50=3.95577 μM | SANGER | |||
| JVM-2 | Growth Inhibition Assay | IC50=3.94752 μM | SANGER | |||
| NH-12 | Growth Inhibition Assay | IC50=3.94187 μM | SANGER | |||
| IST-MES1 | Growth Inhibition Assay | IC50=3.94029 μM | SANGER | |||
| NCI-H69 | Growth Inhibition Assay | IC50=3.90178 μM | SANGER | |||
| KURAMOCHI | Growth Inhibition Assay | IC50=3.86056 μM | SANGER | |||
| NCI-H1155 | Growth Inhibition Assay | IC50=3.84159 μM | SANGER | |||
| NCI-H28 | Growth Inhibition Assay | IC50=3.82961 μM | SANGER | |||
| ES4 | Growth Inhibition Assay | IC50=3.82286 μM | SANGER | |||
| J-RT3-T3-5 | Growth Inhibition Assay | IC50=3.75406 μM | SANGER | |||
| PANC-10-05 | Growth Inhibition Assay | IC50=3.72072 μM | SANGER | |||
| SK-MES-1 | Growth Inhibition Assay | IC50=3.64614 μM | SANGER | |||
| C2BBe1 | Growth Inhibition Assay | IC50=3.64407 μM | SANGER | |||
| A2780 | Growth Inhibition Assay | IC50=3.64089 μM | SANGER | |||
| CaR-1 | Growth Inhibition Assay | IC50=3.61048 μM | SANGER | |||
| SK-LU-1 | Growth Inhibition Assay | IC50=3.60645 μM | SANGER | |||
| OAW-28 | Growth Inhibition Assay | IC50=3.59426 μM | SANGER | |||
| TE-1 | Growth Inhibition Assay | IC50=3.59169 μM | SANGER | |||
| 639-V | Growth Inhibition Assay | IC50=3.57792 μM | SANGER | |||
| C8166 | Growth Inhibition Assay | IC50=3.46521 μM | SANGER | |||
| NTERA-S-cl-D1 | Growth Inhibition Assay | IC50=3.44957 μM | SANGER | |||
| D-542MG | Growth Inhibition Assay | IC50=3.44222 μM | SANGER | |||
| LB771-HNC | Growth Inhibition Assay | IC50=3.39126 μM | SANGER | |||
| NCI-H727 | Growth Inhibition Assay | IC50=3.38584 μM | SANGER | |||
| SW1463 | Growth Inhibition Assay | IC50=3.26192 μM | SANGER | |||
| NCI-H1793 | Growth Inhibition Assay | IC50=3.21098 μM | SANGER | |||
| HT-1376 | Growth Inhibition Assay | IC50=3.20506 μM | SANGER | |||
| 647-V | Growth Inhibition Assay | IC50=3.1622 μM | SANGER | |||
| BCPAP | Growth Inhibition Assay | IC50=3.08295 μM | SANGER | |||
| MN-60 | Growth Inhibition Assay | IC50=3.04974 μM | SANGER | |||
| COLO-680N | Growth Inhibition Assay | IC50=3.00495 μM | SANGER | |||
| DU-4475 | Growth Inhibition Assay | IC50=2.99052 μM | SANGER | |||
| NCI-H1693 | Growth Inhibition Assay | IC50=2.95897 μM | SANGER | |||
| HC-1 | Growth Inhibition Assay | IC50=2.94012 μM | SANGER | |||
| KYSE-510 | Growth Inhibition Assay | IC50=2.86786 μM | SANGER | |||
| OVCAR-3 | Growth Inhibition Assay | IC50=2.85594 μM | SANGER | |||
| PC-3 | Growth Inhibition Assay | IC50=2.83317 μM | SANGER | |||
| BB65-RCC | Growth Inhibition Assay | IC50=2.80713 μM | SANGER | |||
| QIMR-WIL | Growth Inhibition Assay | IC50=2.75952 μM | SANGER | |||
| HuP-T4 | Growth Inhibition Assay | IC50=2.72818 μM | SANGER | |||
| Detroit562 | Growth Inhibition Assay | IC50=2.69845 μM | SANGER | |||
| DMS-79 | Growth Inhibition Assay | IC50=2.69284 μM | SANGER | |||
| MC-IXC | Growth Inhibition Assay | IC50=2.64453 μM | SANGER | |||
| TE-8 | Growth Inhibition Assay | IC50=2.63653 μM | SANGER | |||
| MKN7 | Growth Inhibition Assay | IC50=2.62748 μM | SANGER | |||
| HH | Growth Inhibition Assay | IC50=2.49854 μM | SANGER | |||
| CFPAC-1 | Growth Inhibition Assay | IC50=2.43864 μM | SANGER | |||
| HTC-C3 | Growth Inhibition Assay | IC50=2.42267 μM | SANGER | |||
| NY | Growth Inhibition Assay | IC50=2.3727 μM | SANGER | |||
| KU812 | Growth Inhibition Assay | IC50=2.36779 μM | SANGER | |||
| EW-18 | Growth Inhibition Assay | IC50=2.35471 μM | SANGER | |||
| NCI-H2170 | Growth Inhibition Assay | IC50=2.34783 μM | SANGER | |||
| JVM-3 | Growth Inhibition Assay | IC50=2.34643 μM | SANGER | |||
| IGROV-1 | Growth Inhibition Assay | IC50=2.31237 μM | SANGER | |||
| A498 | Growth Inhibition Assay | IC50=2.29415 μM | SANGER | |||
| BT-20 | Growth Inhibition Assay | IC50=2.26744 μM | SANGER | |||
| SCC-4 | Growth Inhibition Assay | IC50=2.21776 μM | SANGER | |||
| 786-0 | Growth Inhibition Assay | IC50=2.18406 μM | SANGER | |||
| RXF393 | Growth Inhibition Assay | IC50=2.13036 μM | SANGER | |||
| KARPAS-45 | Growth Inhibition Assay | IC50=2.12479 μM | SANGER | |||
| RPMI-8866 | Growth Inhibition Assay | IC50=2.08481 μM | SANGER | |||
| NCI-H2009 | Growth Inhibition Assay | IC50=2.06214 μM | SANGER | |||
| SW1116 | Growth Inhibition Assay | IC50=2.06009 μM | SANGER | |||
| EKVX | Growth Inhibition Assay | IC50=2.04939 μM | SANGER | |||
| TGBC24TKB | Growth Inhibition Assay | IC50=2.02961 μM | SANGER | |||
| CAL-12T | Growth Inhibition Assay | IC50=2.01861 μM | SANGER | |||
| HCC70 | Growth Inhibition Assay | IC50=2.00815 μM | SANGER | |||
| OMC-1 | Growth Inhibition Assay | IC50=1.99888 μM | SANGER | |||
| EPLC-272H | Growth Inhibition Assay | IC50=1.85549 μM | SANGER | |||
| NCI-H209 | Growth Inhibition Assay | IC50=1.77269 μM | SANGER | |||
| NCI-H1666 | Growth Inhibition Assay | IC50=1.74704 μM | SANGER | |||
| COLO-678 | Growth Inhibition Assay | IC50=1.73444 μM | SANGER | |||
| PANC-03-27 | Growth Inhibition Assay | IC50=1.70139 μM | SANGER | |||
| BB30-HNC | Growth Inhibition Assay | IC50=1.68972 μM | SANGER | |||
| ML-2 | Growth Inhibition Assay | IC50=1.64029 μM | SANGER | |||
| BT-549 | Growth Inhibition Assay | IC50=1.58747 μM | SANGER | |||
| HSC-3 | Growth Inhibition Assay | IC50=1.5438 μM | SANGER | |||
| LAMA-84 | Growth Inhibition Assay | IC50=1.53815 μM | SANGER | |||
| SCC-25 | Growth Inhibition Assay | IC50=1.52322 μM | SANGER | |||
| SAS | Growth Inhibition Assay | IC50=1.51622 μM | SANGER | |||
| BE-13 | Growth Inhibition Assay | IC50=1.50671 μM | SANGER | |||
| J82 | Growth Inhibition Assay | IC50=1.45766 μM | SANGER | |||
| 697 | Growth Inhibition Assay | IC50=1.44104 μM | SANGER | |||
| NCI-H526 | Growth Inhibition Assay | IC50=1.43826 μM | SANGER | |||
| RH-1 | Growth Inhibition Assay | IC50=1.41136 μM | SANGER | |||
| CCRF-CEM | Growth Inhibition Assay | IC50=1.4111 μM | SANGER | |||
| NB5 | Growth Inhibition Assay | IC50=1.40894 μM | SANGER | |||
| KMOE-2 | Growth Inhibition Assay | IC50=1.39815 μM | SANGER | |||
| SK-N-DZ | Growth Inhibition Assay | IC50=1.36947 μM | SANGER | |||
| SW48 | Growth Inhibition Assay | IC50=1.36618 μM | SANGER | |||
| SW954 | Growth Inhibition Assay | IC50=1.34048 μM | SANGER | |||
| NCI-H1650 | Growth Inhibition Assay | IC50=1.33482 μM | SANGER | |||
| NKM-1 | Growth Inhibition Assay | IC50=1.32597 μM | SANGER | |||
| NCI-H1092 | Growth Inhibition Assay | IC50=1.3085 μM | SANGER | |||
| CTV-1 | Growth Inhibition Assay | IC50=1.308 μM | SANGER | |||
| GCIY | Growth Inhibition Assay | IC50=1.30132 μM | SANGER | |||
| SW1088 | Growth Inhibition Assay | IC50=1.29607 μM | SANGER | |||
| 769-P | Growth Inhibition Assay | IC50=1.27918 μM | SANGER | |||
| OAW-42 | Growth Inhibition Assay | IC50=1.27825 μM | SANGER | |||
| SNU-449 | Growth Inhibition Assay | IC50=1.22208 μM | SANGER | |||
| MKN1 | Growth Inhibition Assay | IC50=1.21987 μM | SANGER | |||
| NCI-H1648 | Growth Inhibition Assay | IC50=1.10616 μM | SANGER | |||
| KU-19-19 | Growth Inhibition Assay | IC50=1.08541 μM | SANGER | |||
| MHH-PREB-1 | Growth Inhibition Assay | IC50=1.08451 μM | SANGER | |||
| EM-2 | Growth Inhibition Assay | IC50=1.03016 μM | SANGER | |||
| NCI-H1304 | Growth Inhibition Assay | IC50=1.01643 μM | SANGER | |||
| DOHH-2 | Growth Inhibition Assay | IC50=1.00021 μM | SANGER | |||
| MS-1 | Growth Inhibition Assay | IC50=994.69 nM | SANGER | |||
| SK-NEP-1 | Growth Inhibition Assay | IC50=989.44 nM | SANGER | |||
| HT-3 | Growth Inhibition Assay | IC50=982.41 nM | SANGER | |||
| BHY | Growth Inhibition Assay | IC50=975.48 nM | SANGER | |||
| BT-474 | Growth Inhibition Assay | IC50=938.14 nM | SANGER | |||
| CAPAN-1 | Growth Inhibition Assay | IC50=883.29 nM | SANGER | |||
| NCI-H2126 | Growth Inhibition Assay | IC50=882.83 nM | SANGER | |||
| COR-L88 | Growth Inhibition Assay | IC50=882.26 nM | SANGER | |||
| DEL | Growth Inhibition Assay | IC50=877.65 nM | SANGER | |||
| AU565 | Growth Inhibition Assay | IC50=869.6 nM | SANGER | |||
| 23132-87 | Growth Inhibition Assay | IC50=864.28 nM | SANGER | |||
| LoVo | Growth Inhibition Assay | IC50=859.06 nM | SANGER | |||
| TE-12 | Growth Inhibition Assay | IC50=821.11 nM | SANGER | |||
| EC-GI-10 | Growth Inhibition Assay | IC50=788.52 nM | SANGER | |||
| LU-135 | Growth Inhibition Assay | IC50=783.03 nM | SANGER | |||
| A431 | Growth Inhibition Assay | IC50=780.04 nM | SANGER | |||
| TE-6 | Growth Inhibition Assay | IC50=764.31 nM | SANGER | |||
| COLO-684 | Growth Inhibition Assay | IC50=753.01 nM | SANGER | |||
| HAL-01 | Growth Inhibition Assay | IC50=734.71 nM | SANGER | |||
| NCI-H1770 | Growth Inhibition Assay | IC50=722.4 nM | SANGER | |||
| LU-134-A | Growth Inhibition Assay | IC50=719.09 nM | SANGER | |||
| L-363 | Growth Inhibition Assay | IC50=671.94 nM | SANGER | |||
| ETK-1 | Growth Inhibition Assay | IC50=662.59 nM | SANGER | |||
| COR-L105 | Growth Inhibition Assay | IC50=662.53 nM | SANGER | |||
| NBsusSR | Growth Inhibition Assay | IC50=646.52 nM | SANGER | |||
| ME-180 | Growth Inhibition Assay | IC50=632.9 nM | SANGER | |||
| DBTRG-05MG | Growth Inhibition Assay | IC50=632.28 nM | SANGER | |||
| MV-4-11 | Growth Inhibition Assay | IC50=627.7 nM | SANGER | |||
| LB1047-RCC | Growth Inhibition Assay | IC50=625.29 nM | SANGER | |||
| Ramos-2G6-4C10 | Growth Inhibition Assay | IC50=621.46 nM | SANGER | |||
| NB69 | Growth Inhibition Assay | IC50=614.35 nM | SANGER | |||
| FADU | Growth Inhibition Assay | IC50=604.69 nM | SANGER | |||
| NCI-H1623 | Growth Inhibition Assay | IC50=599.36 nM | SANGER | |||
| CAL-39 | Growth Inhibition Assay | IC50=596.3 nM | SANGER | |||
| Ca9-22 | Growth Inhibition Assay | IC50=588.64 nM | SANGER | |||
| CAN | Growth Inhibition Assay | IC50=580.76 nM | SANGER | |||
| RS4-11 | Growth Inhibition Assay | IC50=568.59 nM | SANGER | |||
| DSH1 | Growth Inhibition Assay | IC50=566.88 nM | SANGER | |||
| NB7 | Growth Inhibition Assay | IC50=546.32 nM | SANGER | |||
| NCI-H82 | Growth Inhibition Assay | IC50=540.5 nM | SANGER | |||
| KYSE-180 | Growth Inhibition Assay | IC50=530.62 nM | SANGER | |||
| NCI-H358 | Growth Inhibition Assay | IC50=527.66 nM | SANGER | |||
| SCC-15 | Growth Inhibition Assay | IC50=525.68 nM | SANGER | |||
| HN | Growth Inhibition Assay | IC50=517.38 nM | SANGER | |||
| TK10 | Growth Inhibition Assay | IC50=515.11 nM | SANGER | |||
| MOLT-13 | Growth Inhibition Assay | IC50=514.82 nM | SANGER | |||
| SK-MEL-1 | Growth Inhibition Assay | IC50=510.99 nM | SANGER | |||
| HO-1-N-1 | Growth Inhibition Assay | IC50=509.25 nM | SANGER | |||
| KYSE-270 | Growth Inhibition Assay | IC50=498.65 nM | SANGER | |||
| BPH-1 | Growth Inhibition Assay | IC50=491.16 nM | SANGER | |||
| EFO-27 | Growth Inhibition Assay | IC50=454.74 nM | SANGER | |||
| DoTc2-4510 | Growth Inhibition Assay | IC50=442.12 nM | SANGER | |||
| CTB-1 | Growth Inhibition Assay | IC50=424.4 nM | SANGER | |||
| KY821 | Growth Inhibition Assay | IC50=408.57 nM | SANGER | |||
| NUGC-3 | Growth Inhibition Assay | IC50=401.81 nM | SANGER | |||
| MDA-MB-175-VII | Growth Inhibition Assay | IC50=378.88 nM | SANGER | |||
| CAL-33 | Growth Inhibition Assay | IC50=370.9 nM | SANGER | |||
| KASUMI-1 | Growth Inhibition Assay | IC50=366.73 nM | SANGER | |||
| ECC10 | Growth Inhibition Assay | IC50=352.96 nM | SANGER | |||
| A4-Fuk | Growth Inhibition Assay | IC50=350.02 nM | SANGER | |||
| SK-MEL-24 | Growth Inhibition Assay | IC50=337.87 nM | SANGER | |||
| HCC1806 | Growth Inhibition Assay | IC50=337.51 nM | SANGER | |||
| PC-14 | Growth Inhibition Assay | IC50=333.41 nM | SANGER | |||
| ACHN | Growth Inhibition Assay | IC50=331.4 nM | SANGER | |||
| P12-ICHIKAWA | Growth Inhibition Assay | IC50=328.06 nM | SANGER | |||
| TI-73 | Growth Inhibition Assay | IC50=312.75 nM | SANGER | |||
| CAL-54 | Growth Inhibition Assay | IC50=311.23 nM | SANGER | |||
| SBC-1 | Growth Inhibition Assay | IC50=307.79 nM | SANGER | |||
| BALL-1 | Growth Inhibition Assay | IC50=297.42 nM | SANGER | |||
| CAL-27 | Growth Inhibition Assay | IC50=289.08 nM | SANGER | |||
| NCI-SNU-1 | Growth Inhibition Assay | IC50=283.32 nM | SANGER | |||
| HCE-T | Growth Inhibition Assay | IC50=279.79 nM | SANGER | |||
| MEG-01 | Growth Inhibition Assay | IC50=276.76 nM | SANGER | |||
| CAL-72 | Growth Inhibition Assay | IC50=268.73 nM | SANGER | |||
| KYSE-450 | Growth Inhibition Assay | IC50=247.92 nM | SANGER | |||
| EW-13 | Growth Inhibition Assay | IC50=225.1 nM | SANGER | |||
| DU-145 | Growth Inhibition Assay | IC50=219.04 nM | SANGER | |||
| KYSE-140 | Growth Inhibition Assay | IC50=209.96 nM | SANGER | |||
| CHL-1 | Growth Inhibition Assay | IC50=208.51 nM | SANGER | |||
| KG-1 | Growth Inhibition Assay | IC50=204.34 nM | SANGER | |||
| LB2241-RCC | Growth Inhibition Assay | IC50=194.93 nM | SANGER | |||
| BV-173 | Growth Inhibition Assay | IC50=186.55 nM | SANGER | |||
| LU-65 | Growth Inhibition Assay | IC50=166.61 nM | SANGER | |||
| HSC-2 | Growth Inhibition Assay | IC50=165.57 nM | SANGER | |||
| NCI-H292 | Growth Inhibition Assay | IC50=162.66 nM | SANGER | |||
| H9 | Growth Inhibition Assay | IC50=137.2 nM | SANGER | |||
| DOK | Growth Inhibition Assay | IC50=93.62 nM | SANGER | |||
| HSC-4 | Growth Inhibition Assay | IC50=61.53 nM | SANGER | |||
| DB | Growth Inhibition Assay | IC50=60.96 nM | SANGER | |||
| HuO-3N1 | Growth Inhibition Assay | IC50=56.09 nM | SANGER | |||
| HCC2218 | Growth Inhibition Assay | IC50=50.59 nM | SANGER | |||
| EW-3 | Growth Inhibition Assay | IC50=46.04 nM | SANGER | |||
| NCI-SNU-5 | Growth Inhibition Assay | IC50=28.19 nM | SANGER | |||
| NCI-H720 | Growth Inhibition Assay | IC50=26.92 nM | SANGER | |||
| EoL-1 | Growth Inhibition Assay | IC50=5.17 nM | SANGER | |||
| MIAPaCa2 | Apoptosis Assay | 20 μM | 24 h | DMSO | does not induce apoptosis assessed as caspase 3 activation | 20466555 |
| MIAPaCa2 | Apoptosis Assay | 10 μM | 24h or 48 h | DMSO | does not induce apoptosis | 20466555 |
| MIAPaCa2 | Cytotoxic Assay | 1 μM | 10 d | DMSO | has no cytotoxicity assessed as suppression of colony formation | 20466555 |
| MIAPaCa2 | Growth Inhibition Assay | 2.5 μM | 72 h | DMSO | has no growth inhibition | 20466555 |
| H1975 | Kinase Assay | 0.5 μM | 24 h | DMSO | does not inhibit EGFR L858R/T790M mutant-mediated Akt phosphorylation | 22339342 |
| H1975 | Kinase Assay | 0.5 μM | 24 h | DMSO | does not inhibit EGFR L858R/T790M mutant-mediated Erk phosphorylation | 22339342 |
| H1975 | Kinase Assay | 0.125 μM | 24 h | DMSO | does not inhibit EGFR L858R/T790M mutant Y1068 autophosphorylation | 22339342 |
| H1975 | Kinase Assay | 0.33 μM | 2 h | DMSO | does not inhibit EGFR L858R/T790M double mutant phosphorylation | 24124898 |
| H1975 | Kinase Assay | 0.33 μM | 2 h | DMSO | does not inhibit EGFR L858R/T790M double mutant assessed as reduction in ERK phosphorylation | 24124898 |
| H1975 | Kinase Assay | 0.33 μM | 2 h | DMSO | does not inhibit EGFR L858R/T790M double mutant assessed as reduction in AKT phosphorylation | 24124898 |
| HCC827 | Kinase Assay | 0.11 μM | 1 h | DMSO | has no irreversible inhibition of EGFR assessed as recovery of EGFR autophosphorylation | 24124898 |
| H1975 | Function Assay | 1 μM | 24 h | DMSO | does not inhibit ERK phosphorylation in human H1975 cells harboring EGFR L858R/T790M | 24607591 |
| H1975 | Kinase Assay | 1 μM | 24 h | DMSO | does not inhibit EGFR phosphorylation in human H1975 cells harboring EGFR L858R/T790M mutant | 24607591 |
| LNCaP | Function Assay | 10 μM | 2h or 4 h | DMSO | does not inhibit autophosphorylation of immunopurified flag-tagged Bmx assessed as incorporation of [32P]ATP | 18667312 |
| A431 | Kinase Assay | 1 μM | 1 h | DMSO | has no irreversible inhibition of EGFR autophosphorylation | 24900594 |
| NCI-H1975 | Function Assay | 10 μM | 8 h | DMSO | does not inhibiti EGFR assessed as reduction in ERK phosphorylation | 23116168 |
| HCC827 | Cytotoxic Assay | 0.5 μM | 72 h | DMSO | has no cytotoxicity | 23993328 |
| HCC827 | Function Assay | 0.5 μM | 2 h | DMSO | does not inhibit c-Met assessed as inhibition of p44/42 phosphorylation | 23993328 |
| HCC827 | Function Assay | 0.5 μM | 2 h | DMSO | does not inhibit c-Met assessed as inhibition of AKT phosphorylation | 23993328 |
| SW620 | Cytotoxic Assay | 48 h | DMSO | IC50=28.2 μM | 24900594 | |
| Sf9 | Kinase Assay | 10 min | DMSO | Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) expressed with IC50 of 0.02 μM | 24731281 | |
| HepG2 | Growth Inhibition Assay | 24 h | DMSO | IC50=6.42 μM | 24731281 | |
| Hela | Growth Inhibition Assay | 24 h | DMSO | IC50=2.67 μM | 24731281 | |
| NCI-H1975 | Function Assay | 100 μM | 150 min | DMSO | Induction of NO production in human NCI-H1975 cells harboring EGFR L858R/T790M mutant | 24607591 |
| BEAS2B | Growth Inhibition Assay | 50 μM | 72 h | DMSO | IC50=13.94 μM | 24607591 |
| KB | Kinase Assay | 10 μM | 1 h | DMSO | Inhibition of EGF-stimulated autophosphorylation of EGFR with IC50 of 0.025 μM | 24411123 |
| Calu3 | Cytotoxic Assay | 72 h | DMSO | Cytotoxicity against human Calu3 cells expressing HER2 with IC50 of 0.99 μM | 24411123 | |
| A431 | Cytotoxic Assay | 72 h | DMSO | Cytotoxicity against human A431 cells expressing EGFR with IC50 of 0.55 μM | 24411123 | |
| MDCK2 | Function Assay | 1.8 μM | 72 h | DMSO | Inhibition of human BCRP expressed assessed as Hoechst 33342 accumulation with IC50 of 3.19 μM | 24184213 |
| MDCK | Cytotoxic Assay | 72 h | DMSO | GI50=1.45 μM | 24184213 | |
| BCRP-MDCK2 | Function Assay | 1.8 μM | 72 h | DMSO | Reduction of plasma membrane expression of BCRP expressing reporter gene GFP | 24184213 |
| BCRP-MDCK2 | Function Assay | 1.8 μM | 72 h | DMSO | Increase of plasma membrane expression of BCRP expressing reporter gene GFP | 24184213 |
| A431 | Kinase Assay | 100 μM | 30 min | Inhibition of EGFR in shed membrane vesicles with IC50 of 1.1 μM | 24094432 | |
| HCC827 | Growth Inhibition Assay | 10 μM | 72 h | DMSO | Antiproliferative activity against gefitinib-sensitive human HCC827 cells harboring EGFR E746 to A750 deletion with IC50 of 0.00581 μM | 24053674 |
| HCC827 | Function Assay | 0.5 μM | 2 h | DMSO | Inhibition of c-Met phosphorylation in gefitinib-resistant human HCC827 cells | 23993328 |
| HCC827 | Kinase Assay | 0.5 μM | 2 h | DMSO | Inhibition of EGFR phosphorylation in gefitinib-resistant human HCC827 cells | 23993328 |
| A549 | Function Assay | 1 μM | 1 h | DMSO | Cellular uptake | 23988354 |
| A549 | Kinase Assay | 1 μM | 1 h | DMSO | Inhibition of EGFR autophosphorylation with IC50 of 0.0399 μM | 23988354 |
| HCC827 | Growth Inhibition Assay | 72 h | IC50=0.012 μM | 23973168 | ||
| PC9 | Kinase Assay | 2 h | DMSO | Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells with IC50 of 0.0087 μM | 23930994 | |
| LoVo | Kinase Assay | 2 h | DMSO | Inhibition of EGFR phosphorylation with IC50 of 0.062 μM | 23930994 | |
| SH-SY5Y | Cytotoxic Assay | 72 h | IC50=18.21 μM | 23871909 | ||
| A549 | Growth Inhibition Assay | 72 h | DMSO | Antiproliferative activity against wild type EGFR/k-Ras dependent human A549 cells with IC50 of 4.626 μM | 23792318 | |
| 16HBE | Function Assay | 100 μM | 150 min | DMSO | Induction of nitric oxide production in human 16HBE cells expressing wild type EGFR | 23792318 |
| 16HBE | Growth Inhibition Assay | 72 h | DMSO | Antiproliferative activity against human 16HBE cells expressing wild type EGFR with IC50 of 1.601 μM | 23792318 | |
| NCI-H1975 | Cytotoxic Assay | 10 μM | 72 h | DMSO | Cytotoxicity against gefitinib-resistant human NCI-H1975 cells harboring EGFR L858R/T790M double mutant assessed as growth inhibition with IC50 of 6.917 μM | 23668441 |
| 16HBE14o- | Cytotoxic Assay | 10 μM | 72 h | DMSO | Cytotoxicity against human 16HBE14o- cells harboring wild type EGFR assessed as growth inhibition with IC50 of 12.71 μM | 23668441 |
| Sf9 | Kinase Assay | 1 h | DMSO | Inhibition of human GST-tagged EGFR L834R mutant expressed with IC50 of 0.015 μM | 23611691 | |
| PC9 | Growth Inhibition Assay | 10 μg/mL | 72 h | IC50=0.014 μM | 23116168 | |
| HCC827 | Cytotoxic Assay | 10 μg/mL | 72 h | IC50=0.0015 μM | 23116168 | |
| FADU | Cytotoxic Assay | 10 μg/mL | 72 h | IC50=0.05 μM | 23116168 | |
| Calu3 | Cytotoxic Assay | 10 μg/mL | 72 h | IC50=1.6 μM | 23116168 | |
| A498 | Growth Inhibition Assay | Antiproliferative activity against human A498 cells expressing EGFR and SRC with IC50 of 8.6 μM | 22818848 | |||
| SGC7901 | Cytotoxic Assay | 72 h | IC50=10.26 μM | 22727449 | ||
| HT-29 | Cytotoxic Assay | 72 h | IC50=3.36 μM | 22727449 | ||
| H460 | Cytotoxic Assay | 72 h | IC50=5.59 μM | 22727449 | ||
| A431 | Kinase Assay | 100 μM | 30 min | Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation with IC50 of 1.08 μM | 22698782 | |
| HCC827 | Kinase Assay | 0.125 μM | 24 h | DMSO | Inhibition of EGFR del E746-A750 mutant-mediated Akt phosphorylation | 22339342 |
| HCC827 | Kinase Assay | 0.125 μM | 24 h | DMSO | Inhibition of EGFR del E746-A750 mutant-mediated Erk phosphorylation | 22339342 |
| HCC827 | Kinase Assay | 0.125 μM | 24 h | DMSO | Inhibition of EGFR del E746-A750 mutant Y1068 autophosphorylation | 22339342 |
| MCF7 | Cytotoxic Assay | 10 μM | 48 h | Cytotoxicity against serum-starved human MCF7 cells over-expressing ErbB2 cells | 22138308 | |
| BT474 | Cytotoxic Assay | 10 μM | 48 h | Cytotoxicity against serum-starved human BT474 cells | 22138308 | |
| MCF7 | Growth Inhibition Assay | 100 μg/mL | 48 h | DMSO | Antiproliferative activity against human MCF7 cells overexpressing EGFR gene with IC50 of 12.05 μM | 22119130 |
| A431 | Kinase Assay | 2 h | DMSO | Inhibition of EGFR phosphorylation in EGF-stimulated human A431 with IC50 of 0.001 μM | 22101132 | |
| NCI-H292 | Growth Inhibition Assay | 72 h | DMSO | IC50=0.02 μM | 21916433 | |
| NCI-H1993 | Growth Inhibition Assay | 72 h | DMSO | IC50=0.1 μM | 21916433 | |
| Plasmodium falciparum | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | 21817045 | ||||
| MDA-MB-468 | Growth Inhibition Assay | 100 μM | 48 h | DMSO | Antiproliferative activity | 21429632 |
| PC3 | Growth Inhibition Assay | 10 μM | 72 h | DMSO | IC50=7.4 μM | 21353546 |
| PC9 | Growth Inhibition Assay | Antiproliferative activity against growth-resistant human PC9 cells expressing EGFR E746_A750/T790M mutant with EC50 of 7 μM | 21208802 | |||
| PC9 | Growth Inhibition Assay | Antiproliferative activity against EGFR-deficient human PC9 cells with EC50 of 0.017 μM | 21208802 | |||
| PANC1 | Cytotoxic Assay | 5 d | DMSO | IC50=40.42 μM | 20466555 | |
| MIAPaCa2 | Cytotoxic Assay | 5 d | DMSO | IC50=50.62 μM | 20466555 | |
| DU145 | Cytotoxic Assay | 5 d | DMSO | IC50=42.17 μM | 20466555 | |
| SMMC7721 | Growth Inhibition Assay | 48 h | IC50=33.12 μM | 20304537 | ||
| A375 | Growth Inhibition Assay | 48 h | IC50=20.55 μM | 20304537 | ||
| NCI-H1975 | Function Assay | 5 μM | 48 h | Induction of apoptosis assessed as activation of caspase-3 | 20151670 | |
| NCI-H1975 | Function Assay | 10 μM | Inhibition of ERBB2 autophosphorylation | 20151670 | ||
| NCI-H1975 | Kinase Assay | 10 μM | Inhibition of EGFR autophosphorylation | 20151670 | ||
| NCI-H1975 | Growth Inhibition Assay | 5 μM | 72 h | IC50=8.26 μM | 20151670 | |
| Sf9 | Kinase Assay | 10 min | DMSO | Inhibition of EGFR expressed assessed as inhibition of receptor autophosphorylation with IC50 of 0.033 μM | 20056425 | |
| A431 | Kinase Assay | 100 μM | 10 min | Prolonged inhibitory activity of EGF-induced EGFR phosphorylation | 19969465 | |
| A431 | Kinase Assay | 0.1 μM | 1 h | Inhibition of EGF-induced EGFR phosphorylation | 19969465 | |
| A431 | Growth Inhibition Assay | 10 μM | 72 h | GI50=0.514 μM | 19969465 | |
| MCF7 MX | Function Assay | 30 min | Inhibition of BCRP expressed with IC50 of 1.1 μM | 19932960 | ||
| NIH3T3 | Growth Inhibition Assay | 72 h | Growth inhibition of mouse NIH/3T3 cells expressing erB2 gene with IC50 of 0.54 μM | 19665377 | ||
| BA/F3 | Cytotoxic Assay | 72 h | Cytotoxicity against mouse BA/F3 cells expressing EGFR L858R mutant with IC50 of 0.0108 μM | 19239229 | ||
| HN5 | Growth Inhibition Assay | 72 h | Antiproliferative activity against human HN5 cells overexpressing EGFR with EC50 of 0.01 μM | 19028424 | ||
| BT474 | Growth Inhibition Assay | 72 h | Antiproliferative activity against human BT474 cells overexpressing ERBb2 with EC50 of 0.3 μM | 19028424 | ||
| MCF7 | Cytotoxic Assay | 50 μM | 72 h | IC50=12.05 μM | 18771819 | |
| MOLT4 | Cytotoxic Assay | 96 h | DMSO | IC50=15.02 μM | 18313807 | |
| MDA-MB-231 | Cytotoxic Assay | 96 h | DMSO | IC50=36.61 μM | 18313807 | |
| K562 | Cytotoxic Assay | 96 h | DMSO | IC50=9.36 μM | 18313807 | |
| A549 | Cytotoxic Assay | 96 h | DMSO | IC50=13.59 μM | 18313807 | |
| COS7 | Function Assay | 96 μM | Inhibition of human JAK2 V617F mutant expressed | 17178722 | ||
| NIH3T3 | Function Assay | 0.2 μM | 2 h | DMSO | Inhibition of EGF stimulated human erbB1 autophosphorylation with IC50 of 0.0144 μM | 16480284 |
| KB | Growth Inhibition Assay | IC50=0.054 μM | 16516473 | |||
| GAK | Growth Inhibition Assay | IC50=21.499 μM | 29795767 | |||
| SK-N-AS | Growth Inhibition Assay | IC50=21.5619 μM | 19691349 | |||
| OE33 | Growth Inhibition Assay | IC50=21.6046 μM | 18469809 | |||
| YKG-1 | Growth Inhibition Assay | IC50=21.6545 μM | 22944119 | |||
| CAL-85 | Growth Inhibition Assay | IC50=21.9305 μM | 24631359 | |||
| NCI-H2347 | Growth Inhibition Assay | IC50=21.9428 μM | 28221790 | |||
| PANC-08-13 | Growth Inhibition Assay | IC50=22.0119 μM | 28221790 | |||
| SK-N-FI | Growth Inhibition Assay | IC50=22.3074 μM | 18469809 | |||
| NEC8 | Growth Inhibition Assay | IC50=22.5078 μM | 22944119 | |||
| AN3-CA | Growth Inhibition Assay | IC50=22.6084 μM | 22944119 | |||
| HuO9 | Growth Inhibition Assay | IC50=22.7396 μM | 27032331 | |||
| COLO-800 | Growth Inhibition Assay | IC50=22.7653 μM | 24341356 | |||
| HT-29 | Growth Inhibition Assay | IC50=22.8823 μM | 21711054 | |||
| OC-314 | Growth Inhibition Assay | IC50=22.8845 μM | 20873740 | |||
| G-401 | Growth Inhibition Assay | IC50=23.0462 μM | 18469809 | |||
| Saos-2 | Growth Inhibition Assay | IC50=23.5182 μM | 24471998 | |||
| UACC-62 | Growth Inhibition Assay | IC50=23.5833 μM | 19691349 | |||
| D-247MG | Growth Inhibition Assay | IC50=23.7939 μM | 18469809 | |||
| COLO-741 | Growth Inhibition Assay | IC50=23.9565 μM | 20580554 | |||
| ES3 | Growth Inhibition Assay | IC50=24.0023 μM | 28221790 | |||
| LNCaP-Clone-FGC | Growth Inhibition Assay | IC50=24.0211 μM | 28221790 | |||
| SW1710 | Growth Inhibition Assay | IC50=24.1506 μM | 23094992 | |||
| LU-99A | Growth Inhibition Assay | IC50=24.1841 μM | 17602464 | |||
| HOP-92 | Growth Inhibition Assay | IC50=24.725 μM | 24471998 | |||
| LS-123 | Growth Inhibition Assay | IC50=24.9614 μM | 22342146 | |||
| T84 | Growth Inhibition Assay | IC50=24.9765 μM | 29328656 | |||
| HCT-116 | Growth Inhibition Assay | IC50=25.4186 μM | 29471119 | |||
| M14 | Growth Inhibition Assay | IC50=25.4447 μM | 17602464 | |||
| OCUB-M | Growth Inhibition Assay | IC50=25.4456 μM | 21711054 | |||
| MKN45 | Growth Inhibition Assay | IC50=25.6315 μM | 26025875 | |||
| LCLC-97TM1 | Growth Inhibition Assay | IC50=25.7285 μM | 18588281 | |||
| RVH-421 | Growth Inhibition Assay | IC50=25.8161 μM | 20873740 | |||
| NKS-81-FD | Growth Inhibition Assay | IC50=25.9021 μM | 28221790 | |||
| NCI-H596 | Growth Inhibition Assay | IC50=26.0487 μM | 25703296 | |||
| GB-1 | Growth Inhibition Assay | IC50=26.1879 μM | 17602464 | |||
| ZR-75-30 | Growth Inhibition Assay | IC50=26.2297 μM | 17602464 | |||
| U-2-OS | Growth Inhibition Assay | IC50=26.3757 μM | 22342146 | |||
| HuP-T3 | Growth Inhibition Assay | IC50=26.6102 μM | 21711054 | |||
| MOLT-16 | Growth Inhibition Assay | IC50=26.6166 μM | 17602464 | |||
| U-87-MG | Growth Inhibition Assay | IC50=26.7438 μM | 19362474 | |||
| 8505C | Growth Inhibition Assay | IC50=26.9126 μM | 18588281 | |||
| SK-MEL-3 | Growth Inhibition Assay | IC50=26.9828 μM | 22342146 | |||
| COLO-824 | Growth Inhibition Assay | IC50=27.2195 μM | 24631359 | |||
| EW-1 | Growth Inhibition Assay | IC50=27.3554 μM | 29656202 | |||
| UACC-257 | Growth Inhibition Assay | IC50=27.3804 μM | 28221790 | |||
| Hs-578-T | Growth Inhibition Assay | IC50=27.5299 μM | 24631359 | |||
| UACC-893 | Growth Inhibition Assay | IC50=27.6631 μM | 22342146 | |||
| MHH-NB-11 | Growth Inhibition Assay | IC50=27.8007 μM | 20873740 | |||
| KYSE-410 | Growth Inhibition Assay | IC50=28.2779 μM | 21711054 | |||
| SF126 | Growth Inhibition Assay | IC50=28.7435 μM | 21711054 | |||
| HT-144 | Growth Inhibition Assay | IC50=29.3362 μM | 22342146 | |||
| SW1573 | Growth Inhibition Assay | IC50=29.3509 μM | 26025875 | |||
| SW620 | Growth Inhibition Assay | IC50=29.3641 μM | 28075592 | |||
| SCH | Growth Inhibition Assay | IC50=29.8831 μM | 20873740 | |||
| EW-22 | Growth Inhibition Assay | IC50=30.1969 μM | 25703296 | |||
| H4 | Growth Inhibition Assay | IC50=30.4654 μM | 26025875 | |||
| CAS-1 | Growth Inhibition Assay | IC50=30.7859 μM | 24471998 | |||
| MG-63 | Growth Inhibition Assay | IC50=30.8478 μM | 21711054 | |||
| MDA-MB-415 | Growth Inhibition Assay | IC50=31.1753 μM | 18469809 | |||
| NCI-H1395 | Growth Inhibition Assay | IC50=31.2328 μM | 19362474 | |||
| Ca-Ski | Growth Inhibition Assay | IC50=31.3177 μM | 18469809 | |||
| BxPC-3 | Growth Inhibition Assay | IC50=31.3729 μM | 24631359 | |||
| A3-KAW | Growth Inhibition Assay | IC50=31.4471 μM | 17602464 | |||
| T-24 | Growth Inhibition Assay | IC50=31.7362 μM | 20580554 | |||
| NCI-H2029 | Growth Inhibition Assay | IC50=31.7765 μM | 24471998 | |||
| YAPC | Growth Inhibition Assay | IC50=32.0407 μM | 21711054 | |||
| SK-MEL-2 | Growth Inhibition Assay | IC50=32.052 μM | 19362474 | |||
| LS-513 | Growth Inhibition Assay | IC50=32.1187 μM | 19362474 | |||
| AsPC-1 | Growth Inhibition Assay | IC50=32.3605 μM | 17101674 | |||
| KYSE-150 | Growth Inhibition Assay | IC50=32.3773 μM | 23230131 | |||
| NCI-H520 | Growth Inhibition Assay | IC50=32.4482 μM | 21711054 | |||
| JEG-3 | Growth Inhibition Assay | IC50=33.0971 μM | 23230131 | |||
| GMS-10 | Growth Inhibition Assay | IC50=33.3004 μM | 21711054 | |||
| HT-1080 | Growth Inhibition Assay | IC50=33.39 μM | 24195466 | |||
| NCI-H1651 | Growth Inhibition Assay | IC50=33.396 μM | 19362474 | |||
| NCI-H2122 | Growth Inhibition Assay | IC50=33.5574 μM | 20873740 | |||
| ES5 | Growth Inhibition Assay | IC50=33.7292 μM | 29656202 | |||
| 8305C | Growth Inhibition Assay | IC50=33.9937 μM | 19362474 | |||
| KM12 | Growth Inhibition Assay | IC50=34.0478 μM | 23230131 | |||
| HCT-15 | Growth Inhibition Assay | IC50=34.127 μM | 23968824 | |||
| OVCAR-5 | Growth Inhibition Assay | IC50=34.2182 μM | 24867590 | |||
| NCI-H2291 | Growth Inhibition Assay | IC50=34.2472 μM | 23230131 | |||
| CP50-MEL-B | Growth Inhibition Assay | IC50=34.6592 μM | 25105722 | |||
| C-33-A | Growth Inhibition Assay | IC50=34.6857 μM | 27966950 | |||
| NCI-H2452 | Growth Inhibition Assay | IC50=34.7882 μM | 21711054 | |||
| MDA-MB-157 | Growth Inhibition Assay | IC50=34.8193 μM | 19362474 | |||
| LN-405 | Growth Inhibition Assay | IC50=35.4308 μM | 20873740 | |||
| MDA-MB-231 | Growth Inhibition Assay | IC50=35.5054 μM | 23360104 | |||
| EW-24 | Growth Inhibition Assay | IC50=35.6335 μM | 23968824 | |||
| MKN28 | Growth Inhibition Assay | IC50=35.8236 μM | 19362474 | |||
| KINGS-1 | Growth Inhibition Assay | IC50=35.8434 μM | 29328656 | |||
| LC-2-ad | Growth Inhibition Assay | IC50=36.699 μM | 25703296 | |||
| IGR-1 | Growth Inhibition Assay | IC50=36.7075 μM | 24436994 | |||
| SW626 | Growth Inhibition Assay | IC50=37.0417 μM | 22512908 | |||
| ONS-76 | Growth Inhibition Assay | IC50=37.1309 μM | 23968824 | |||
| T98G | Growth Inhibition Assay | IC50=37.8635 μM | 21711054 | |||
| NB14 | Growth Inhibition Assay | IC50=38.4544 μM | 24436994 | |||
| D-423MG | Growth Inhibition Assay | IC50=38.4869 μM | 19362474 | |||
| NCI-H510A | Growth Inhibition Assay | IC50=38.6451 μM | 28495081 | |||
| NMC-G1 | Growth Inhibition Assay | IC50=38.7222 μM | 21711054 | |||
| SW948 | Growth Inhibition Assay | IC50=38.8949 μM | 24341356 | |||
| MFM-223 | Growth Inhibition Assay | IC50=38.9431 μM | 17419604 | |||
| PAN1 | Growth Inhibition Assay | IC50=38.9919 μM | 22512908 | |||
| MZ7-mel | Growth Inhibition Assay | IC50=39.1199 μM | 28075592 | |||
| COLO-679 | Growth Inhibition Assay | IC50=39.9708 μM | 21711054 | |||
| SW872 | Growth Inhibition Assay | IC50=40.2031 μM | 24631359 | |||
| HT-1197 | Growth Inhibition Assay | IC50=40.2869 μM | 27349332 | |||
| ES6 | Growth Inhibition Assay | IC50=40.4552 μM | 18186604 | |||
| SNU-387 | Growth Inhibition Assay | IC50=40.8238 μM | 17419604 | |||
| T47D | Growth Inhibition Assay | IC50=41.0192 μM | 18186604 | |||
| G-402 | Growth Inhibition Assay | IC50=41.0809 μM | 23489626 | |||
| MZ1-PC | Growth Inhibition Assay | IC50=41.81 μM | 17602464 | |||
| SW1417 | Growth Inhibition Assay | IC50=42.303 μM | 17602464 | |||
| RERF-LC-MS | Growth Inhibition Assay | IC50=42.5087 μM | 28576633 | |||
| SF539 | Growth Inhibition Assay | IC50=42.5529 μM | 23489626 | |||
| ESS-1 | Growth Inhibition Assay | IC50=43.5558 μM | 28576633 | |||
| RO82-W-1 | Growth Inhibition Assay | IC50=43.6153 μM | 28576633 | |||
| S-117 | Growth Inhibition Assay | IC50=43.6958 μM | 22512908 | |||
| SW756 | Growth Inhibition Assay | IC50=43.8242 μM | SANGER | |||
| CP66-MEL | Growth Inhibition Assay | IC50=45.7143 μM | SANGER | |||
| H-EMC-SS | Growth Inhibition Assay | IC50=45.7693 μM | SANGER | |||
| NCI-H2052 | Growth Inhibition Assay | IC50=45.9027 μM | SANGER | |||
| SW684 | Growth Inhibition Assay | IC50=47.0081 μM | SANGER | |||
| HCC1569 | Growth Inhibition Assay | IC50=47.1658 μM | SANGER | |||
| KGN | Growth Inhibition Assay | IC50=47.3311 μM | SANGER | |||
| LCLC-103H | Growth Inhibition Assay | IC50=47.4404 μM | SANGER | |||
| SW780 | Growth Inhibition Assay | IC50=47.6351 μM | SANGER | |||
| NCI-H1703 | Growth Inhibition Assay | IC50=48.3352 μM | SANGER | |||
| HCC1395 | Growth Inhibition Assay | IC50=48.7432 μM | SANGER | |||
| 클릭하여 더 많은 세포주 실험 데이터 보기 | ||||||
| 분자량 | 446.90 | 화학식 | C22H24ClFN4O3 |
보관 (수령일로부터) | |
|---|---|---|---|---|---|
| CAS 번호 | 184475-35-2 | SDF 다운로드 | 원액 보관 |
|
|
| 동의어 | ZD1839 | Smiles | COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 | ||
|
In vitro |
DMSO
: 89 mg/mL
(199.14 mM)
Ethanol : 4 mg/mL Water : Insoluble |
|
In vivo |
|||||
1단계: 아래 정보 입력 (권장: 실험 중 손실을 고려하여 추가 동물 포함)
2단계: 생체 내 제형 입력 (이것은 계산기일 뿐 제형이 아닙니다. 용해도 섹션에 생체 내 제형이 없는 경우 먼저 당사에 문의하십시오.)
계산 결과:
작업 농도: mg/ml;
DMSO 원액 준비 방법: mg 약물 사전 용해 μL DMSO ( 원액 농도 mg/mL, 농도가 해당 약물 배치의 DMSO 용해도를 초과하는 경우 먼저 당사에 문의하십시오. )
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가μL PEG300, 혼합하고 투명하게 한 다음 추가μL Tween 80, 혼합하고 투명하게 한 다음 추가 μL ddH2O, 혼합하고 투명하게 합니다.
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가 μL 옥수수 기름, 혼합하고 투명하게 합니다.
참고: 1. 다음 용매를 추가하기 전에 액체가 투명한지 확인하십시오.
2. 용매를 순서대로 추가해야 합니다. 다음 용매를 추가하기 전에 이전 추가에서 얻은 용액이 투명한 용액인지 확인해야 합니다. 와동, 초음파 또는 뜨거운 물 중탕과 같은 물리적 방법을 사용하여 용해를 도울 수 있습니다.
| 특징 |
A potent EGFR tyrosine kinase inhibitor.
|
|---|---|
| Targets/IC50/Ki |
Tyr1173 (NR6W cells)
26 nM
Tyr1173 (NR6wtEGFR cells)
37 nM
Tyr992 (NR6wtEGFR cells)
37 nM
Tyr992 (NR6W cells)
57 nM
|
| 시험관 내(In vitro) |
Gefitinib은 NR6, NR6M 및 NR6W 세포주를 포함하여 EGFR을 높게 또는 낮게 발현하는 세포주 모두에서 EGFR의 모든 티로신 인산화 부위를 효과적으로 억제합니다. 인산화 부위 Tyr1173 및 Tyr992는 억제를 위해 이 화합물의 더 높은 농도를 필요로 하는 덜 민감한 부위입니다. NR6W 세포에서 IC50 27 nM로 PLC-γ의 인산화를 효과적으로 차단합니다. NR6wtEGFR 및 NR6M 세포주는 낮은 수준의 PLC-γ 인산화를 보이지만, NR6M 세포주의 수준은 이 화학물질에 의한 억제에 더 강하며, 각각 43 nM 및 369 nM의 IC50을 가집니다. 이 화합물은 EGFR을 낮게 발현하는 세포주 및 EGFRvIII을 발현하는 세포주에서 Akt 인산화를 IC50 220 및 263 nM로 억제합니다. 0.1~0.5 μM의 용량 범위에서 NR6M 세포의 콜로니 형성을 억제하기보다는 유의하게 촉진합니다. 그러나 2 μM 농도에서는 이 화학물질이 NR6M 콜로니 형성을 완전히 차단합니다. EGFR을 높게 및 낮게 발현하는 세포주 모두에서 EGF 자극 후 최대 72시간까지 EGFR 및 ERK 인산화를 빠르고 용량 의존적으로 억제합니다. 이 화합물은 EGF 구동형 비변형 MCF10A 세포의 단층 성장으로, IC50은 20 nM입니다. 이 화학물질(0.2 μM 및 0.5 μM)과 방사선 조사의 조합은 방사선 단독과 비교하여 LoVo 세포에서 유의한 성장 억제를 유도합니다. |
| 생체 내(In vivo) |
Gefitinib (100 mg/kg)은 LoVo 종양 이종이식에서 방사선 치료의 항종양 효과를 향상시킵니다. 이 화합물로 확립된 인간 GEO 결장암 이종이식을 가진 누드 마우스를 치료한 결과, GEO 종양이 치료 종료 시 대조군의 성장률을 회복하기 때문에 종양 성장의 가역적인 용량 의존적 억제가 나타납니다. |
참조 |
|
| 방법 | 바이오마커 | 이미지 | PMID |
|---|---|---|---|
| Western blot | phospho-EGFR / phospho-ERK / phospho-SRC / phospho-AKT Cyclin D1/ p16 / p27 / pRb uc-caspase-9 / c-caspase-9 / uc-caspase-3 / c-caspase-3 / uc-PARP / PARP PPAR-γ |
|
22586683 |
| Immunofluorescence | EGFR / LC3 PPAR-γ p-EGFR / β-catenin |
|
31196210 |
| Growth inhibition assay | GI50 |
|
23409107 |
(데이터 출처 https://clinicaltrials.gov, 업데이트 날짜 2024-05-22)
| NCT 번호 | 모집 | 조건 | 스폰서/협력자 | 시작일 | 단계 |
|---|---|---|---|---|---|
| NCT03599518 | Terminated | Non Small Cell Lung Cancer |
Daiichi Sankyo Co. Ltd.|Daiichi Sankyo |
September 21 2018 | Phase 1 |
| NCT03292133 | Active not recruiting | Lung Cancer |
Massachusetts General Hospital|Novartis |
October 31 2017 | Phase 2 |
| NCT03122717 | Active not recruiting | Non-Small Cell Lung Cancer |
Dana-Farber Cancer Institute|AstraZeneca |
May 9 2017 | Phase 1|Phase 2 |
| NCT02932345 | Terminated | EGFR Mutation Positive Advanced Non-small-cell Lung Cancer |
AstraZeneca |
October 31 2016 | -- |
| NCT02824458 | Unknown status | EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors |
Sun Yat-sen University |
June 2016 | Phase 3 |
질문 1:
I try to dissolve it in 0.5% methylcellulose+0.2% Tween 80 for in vivo experiments. However, when I prepare the mixture, this compound forms precipitates. Exists another way to dissolve completely it?
답변:
It can be dissolved in both 5% DMSO+corn oil and 5% DMSO+30% PEG 300+5% Tween 80+ddH2O at 2.5 mg/ml clearly. It dissolves in DMSO not readily, please sonicate and warm it in water bath at about 45 degree, and dissolve it clearly first. Then add other solvent.